Lilly stockpiles $1.5B worth of weight loss pill ahead of US approvalnews2026-02-13T15:00:35+00:00February 13th, 2026|Endpoints News|
Immunic’s private placement; Vertex’s cystic fibrosis data in young kidsnews2026-02-13T14:45:37+00:00February 13th, 2026|Endpoints News|
Paul Hudson couldn’t quite get Sanofi over the hump; PROTAC developer Arvinas appoints CEOnews2026-02-13T12:00:16+00:00February 13th, 2026|Endpoints News|
PTC Therapeutics withdraws US filing for troubled Duchenne treatment Translarnanews2026-02-13T11:42:19+00:00February 13th, 2026|Endpoints News|
Updated: Ultragenyx to lay off about 130 employees, resubmit rare disease application againnews2026-02-13T00:50:07+00:00February 13th, 2026|Endpoints News|
Icon’s stock drops 40% after disclosing internal accounting probenews2026-02-12T20:30:10+00:00February 12th, 2026|Endpoints News|
AbbVie sues over selection of Botox for IRA negotiationsnews2026-02-12T19:36:28+00:00February 12th, 2026|Endpoints News|
Pharma pushes back on FDA plans to ease prescription-OTC drug switchesnews2026-02-12T18:35:50+00:00February 12th, 2026|Endpoints News|
Novo Nordisk to expand Irish factory for Wegovy pillnews2026-02-12T17:55:57+00:00February 12th, 2026|Endpoints News|
Cassidy bill seeks to ban a customs loophole on pharma’s radarnews2026-02-12T16:58:11+00:00February 12th, 2026|Endpoints News|
